This study looked at the effectiveness of vitamin B12 in people with type 2 diabetes (T2D) and loss of nerve function. It found that the vitamin improved pain, sensation, and quality of life in these patients.

This research evaluated the effect of dapagliflozin on weight loss in patients with type 2 diabetes mellitus (T2DM) uncontrolled with metformin therapy. The results showed that dapagliflozin reduced blood sugar levels by reducing patients’ weight and increasing the elimination of glucose in urine.

This study examined whether an online intervention with mobile phone support is effective in reducing depressive symptoms in type 1 and type 2 diabetic patients.

This review looked at how SGLT2 inhibitor medications affected the health of patients with type 2 diabetes (T2D). It found that SGLT2 inhibitors improved body weight and heart and liver health in these patients.

This study examined the risk of serious cardiovascular events, such as heart attack and stroke, in patients with type 2 diabetes (T2D). It found that hypoglycemia (low blood-glucose) was associated with an increased risk of these events.

This study investigated the blood sugar reduction and sid-effects associated with 4 different drug combinations in type 2 diabetes.

This study compared nervous system function in latent autoimmune diabetes in adults (LADA) and type 2 diabetes (T2D). 

This study aimed to investigate the effect of saxagliptin (Onglyza) on blood sugar levels and the rate of disease progression in type 2 diabetes.

This article examined dulaglutide (Trulicity) in patients with type 2 diabetes (T2D). It found that dulaglutide was effective and tolerable. 

This study examined the associations between glucose levels, beta cell function, and glucose measures in pre- and type 2 diabetes.